ClinicalTrials.Veeva

Menu

Role of Intima-media Thickness in Determining Arteriogenic Erectile Dysfunction

A

Adam International Hospital

Status

Completed

Conditions

Erectile Dysfunction

Treatments

Device: Penile Duplex

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Erectile dysfunction.

Full description

The intima media thickness is increasingly used as a surrogate end point of vascular outcomes in clinical trials aimed at determining the success of interventions that lower risk factors for atherosclerosis and associated diseases (stroke, myocardial infarction and peripheral artery diseases, like disease of cavernosal artery). The investigators hypothesized that the IMT of cavernosal artery would add to the predictive value of vasculogenic erectile dysfunction risk and outcomes. This study seeks to evaluate these hypotheses with our experience, investigating the predictive accuracy of Cavernosal Doppler ultrasound findings for discriminating patients with vasculogenic erectile dysfunction.

Enrollment

70 patients

Sex

Male

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Erectile dysfunction patients

Exclusion criteria

  • Penile trauma.

Trial design

70 participants in 1 patient group

Penile Duplex
Description:
Measuring intima media thickness
Treatment:
Device: Penile Duplex

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems